Pubblicazioni

A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors

2024 - JOURNAL OF PATHOLOGY

Segatto, Ilenia; Mattevi, Maria Chiara; Rampioni Vinciguerra, Gian Luca; Crestan, Nicole; Musco, Lorena; Favero, Andrea; Dall'Acqua, Alessandra; Di Giustino, Gabriele; Mungo, Giorgia; D'Andrea, Sara; Gava, Chiara; Ruggiero, Federica; Dugo, Matteo; Gerratana, Lorenzo; Puglisi, Fabio; Massarut, Samuele; Bomben, Riccardo; Callari, Maurizio; Perin, Tiziana; Baldassarre, Gustavo; Belletti, Barbara

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review

2022 - FRONTIERS IN ONCOLOGY

Rampioni Vinciguerra, Gian Luca; Sonego, Maura; Segatto, Ilenia; DallâAcqua, Alessandra; Vecchione, Andrea; Baldassarre, Gustavo; Belletti, Barbara

Definition of High-Risk Early Hormone-Positive HER2âNegative Breast Cancer: A Consensus Review

2022 - CANCERS

Botticelli, Andrea

Definition of High-Risk Early Hormone-Positive HER2âNegative Breast Cancer: A Consensus Review

2022 - CANCERS

Garutti, Mattia; Griguolo, Gaia; Botticelli, Andrea; Buzzatti, Giulia; De Angelis, Carmine; Gerratana, Lorenzo; Molinelli, Chiara; Adamo, Vincenzo; Bianchini, Giampaolo; Biganzoli, Laura; Curigliano, Giuseppe; De Laurentiis, Michelino; Fabi, Alessandra; Frassoldati, Antonio; Gennari, Alessandra; MarchiÃ², Caterina; Perrone, Francesco; Viale, Giuseppe; Zamagni, Claudio; Zambelli, Alberto; Del Mastro, Lucia; De Placido, Sabino; Guarneri, Valentina; Marchetti, Paolo; Puglisi, Fabio

Regulatory interplay between mir-181a-5p and estrogen receptor signaling cascade in breast cancer

2021 - CANCERS

Benedetti, R.; Papulino, C.; Sgueglia, G.; Chianese, U.; De Marchi, T.; Iovino, F.; Rotili, D.; Mai, A.; Nimeus, E.; Aversana, C. D.; Altucci, L.

Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Barchiesi, G.; Mazzotta, M.; Krasniqi, E.; Pizzuti, L.; Marinelli, D.; Capomolla, E.; Sergi, D.; Amodio, A.; Natoli, C.; Gamucci, T.; Vizza, E.; Marchetti, P.; Botti, C.; Sanguineti, G.; Ciliberto, G.; Barba, M.; Vici, P.

Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences

2018 - CANCER BIOLOGY & MEDICINE

Peccatori, Fedro Alessandro; Lambertini, Matteo; Scarfone, Giovanna; Del Pup, Lino; Codacci-Pisanelli, Giovanni

Patient database analysis of fulvestrant 500Â mg in the treatment of metastatic breast cancer: A European perspective

2017 - THE BREAST

Marchetti, Paolo; Maass, Nicolai; Gligorov, Joseph; Berger, Karin; Macdougall, Finlay; Montonen, Jukka; Lewis, Jan

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer. Results of the OXYTAM study

2017 - JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Dalenc, Florence; Iuliano, Luigi; Filleron, Thomas; Zerbinati, Chiara; Voisin, Maud; Arellano, CÃ©cile; Chatelut, Etienne; Marquet, Pierre; Samadi, Mohammad; RochÃ©, Henri; Poirot, Marc; Silvente-Poirot, Sandrine

Endocrine therapy in post-menopausal women with metastatic breast cancer: From literature and guidelines to clinical practice

2016 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Sini, Valentina; Cinieri, Saverio; Conte, Pierfranco; De Laurentiis, Michelino; Leo, Angelo Di; Tondini, Carlo; Marchetti, Paolo